Company news
Mirum Pharmaceuticals, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Mirum Pharmaceuticals Presents Data Demonstrating Long-term Durability of Treatment Effect of Maralixibat in Children With Cholestatic Liver Diseases
November 7, 2019
Mirum Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
November 5, 2019
Mirum Pharmaceuticals Announces Appointment of Ed Tucker as Chief Medical Officer
October 27, 2019
Mirum Pharmaceuticals to Present New Data at The Liver Meeting 2019
September 30, 2019
Mirum Pharmaceuticals Announces Pricing of Initial Public Offering
July 16, 2019
Calls
The 5 newest of 21 calls. Every call is listed under its year.
- Mirum Pharmaceuticals (NASDAQ:MIRM) Q3 2026 Earnings Call
Nov 3, 2026
Transcript - Mirum Pharmaceuticals (NASDAQ:MIRM) Q2 2026 Earnings Call
Aug 5, 2026
Transcript - Mirum Pharmaceuticals (NASDAQ:MIRM) Q1 2026 Earnings Call
May 6, 2026
Transcript - Mirum Pharmaceuticals (NASDAQ:MIRM) Q4 2025 Earnings Call
Feb 25, 2026
Transcript - Mirum Pharmaceuticals (NASDAQ:MIRM) Q3 2025 Earnings Call
Nov 4, 2025
Transcript
Decks
The 5 newest of 26 decks. Every deck is listed under its year.
- Corporate Update (October 2026)
Corporate update · 13 slides · Oct 12, 2026
- Corporate Update (September 2026)
Corporate update · 11 slides · Sep 28, 2026
- Technical Presentation (June 2026)
Technical · 6 slides · Jun 12, 2026
- Corporate Update (May 2026)
Corporate update · 20 slides · May 4, 2026
- Technical Presentation (May 2026)
Technical · 20 slides · May 2026